Budesonide vs Insulin Glargine: side-by-side comparison
Budesonide (Inhaled corticosteroid) and Insulin Glargine (Long-acting insulin analogue) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Budesonide | Insulin Glargine |
|---|---|---|
| Therapeutic class | Inhaled corticosteroid | Long-acting insulin analogue |
| CAS | 51333-22-3 | 160337-95-1 |
| ATC | R03BA02 | A10AE04 |
| Molecular weight | 430.53 g/mol | 6063 Da |
| Brands with this active ingredient | 1 | 1 |
What they share
Budesonide and Insulin Glargine share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Budesonide acts by a different mechanism than Insulin Glargine, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Budesonide: Budesonide binds intracellular glucocorticoid receptors and modulates gene transcription, decreasing the synthesis of proinflammatory cytokines, chemokines and adhesion molecules and reducing the recruitment of inflammat… Insulin Glargine: Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic glucose production an…
Indications compared
Budesonide: Budesonide is approved as maintenance therapy in asthma and COPD as inhaled corticosteroid; as topical nasal therapy in allergic rhinitis and nasal polyps; and in extended-release oral formulations for the induction and… Insulin Glargine: Insulin glargine is approved as basal insulin therapy in adults and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus when oral or non-insulin injectable therapy is insufficien…
Safety profile
Budesonide: Local adverse effects include oral candidiasis, dysphonia and pharyngeal irritation, mostly preventable by mouth rinsing after use. Insulin Glargine: Hypoglycaemia is the most important adverse effect of any insulin and can be severe in case of missed meals, prolonged exercise, alcohol intake or interaction with other glucose-lowering agents.
Frequently asked questions
Is Budesonide better than Insulin Glargine? ▾
Budesonide and Insulin Glargine are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Budesonide and Insulin Glargine be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Budesonide
Products with Insulin Glargine
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.